156 related articles for article (PubMed ID: 36661213)
21. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
22. Predictors of non-participation in cervical screening in Denmark.
Kristensson JH; Sander BB; von Euler-Chelpin M; Lynge E
Cancer Epidemiol; 2014 Apr; 38(2):174-80. PubMed ID: 24447699
[TBL] [Abstract][Full Text] [Related]
23. The Short-Term Impact Of COVID-19 Pandemic on Cervical Cancer Screening: A Systematic Review and Meta-Analysis.
Sasidharanpillai S; Ravishankar N
Asian Pac J Cancer Prev; 2022 May; 23(5):1497-1504. PubMed ID: 35633530
[TBL] [Abstract][Full Text] [Related]
24. A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC).
Kitchener HC; Gittins M; Rivero-Arias O; Tsiachristas A; Cruickshank M; Gray A; Brabin L; Torgerson D; Crosbie EJ; Sargent A; Roberts C
Health Technol Assess; 2016 Sep; 20(68):1-138. PubMed ID: 27632816
[TBL] [Abstract][Full Text] [Related]
25. Effect of an Intervention in General Practice to Increase the Participation of Immigrants in Cervical Cancer Screening: A Cluster Randomized Clinical Trial.
Møen KA; Kumar B; Igland J; Diaz E
JAMA Netw Open; 2020 Apr; 3(4):e201903. PubMed ID: 32236530
[TBL] [Abstract][Full Text] [Related]
26. Non-participation in breast cancer screening for women with chronic diseases and multimorbidity: a population-based cohort study.
Jensen LF; Pedersen AF; Andersen B; Vestergaard M; Vedsted P
BMC Cancer; 2015 Oct; 15():798. PubMed ID: 26502879
[TBL] [Abstract][Full Text] [Related]
27. Socioeconomic factors and colorectal cancer incidence, stage and quality of care in Denmark during the COVID-19 pandemic.
Weinberger Rosen A; Jensen H; Olesen TB; Møller H; Jensen JW; Gögenur I
Cancer Epidemiol; 2023 Oct; 86():102447. PubMed ID: 37633057
[TBL] [Abstract][Full Text] [Related]
28. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
BMC Cancer; 2018 Mar; 18(1):273. PubMed ID: 29523108
[TBL] [Abstract][Full Text] [Related]
29. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
30. Impact of the COVID-19 pandemic on breast cancer screening indicators in a Spanish population-based program: a cohort study.
Bosch G; Posso M; Louro J; Roman M; Porta M; Castells X; Macià F
Elife; 2022 Jun; 11():. PubMed ID: 35686727
[TBL] [Abstract][Full Text] [Related]
31. The COVIDPregDK Study: A national survey on pregnancy during the early COVID-19 pandemic in Denmark.
Stokholm L; Schrøder K; Nøhr EA; Rubin KH; Jørgensen JS; Petersen LK; Bliddal M
Scand J Public Health; 2022 Aug; 50(6):703-710. PubMed ID: 34641709
[TBL] [Abstract][Full Text] [Related]
32. Invitation to cervical cancer screening does increase participation in Germany: Results from the MARZY study.
Radde K; Gottschalk A; Bussas U; Schülein S; Schriefer D; Seifert U; Neumann A; Kaiser M; Blettner M; Klug SJ
Int J Cancer; 2016 Sep; 139(5):1018-30. PubMed ID: 27083776
[TBL] [Abstract][Full Text] [Related]
33. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
[TBL] [Abstract][Full Text] [Related]
34. Hospital admission and mortality rates for non-covid diseases in Denmark during covid-19 pandemic: nationwide population based cohort study.
Bodilsen J; Nielsen PB; Søgaard M; Dalager-Pedersen M; Speiser LOZ; Yndigegn T; Nielsen H; Larsen TB; Skjøth F
BMJ; 2021 May; 373():n1135. PubMed ID: 34035000
[TBL] [Abstract][Full Text] [Related]
35. Disparities in cervical screening participation: a comparison of Russian, Somali and Kurdish immigrants with the general Finnish population.
Idehen EE; Koponen P; Härkänen T; Kangasniemi M; Pietilä AM; Korhonen T
Int J Equity Health; 2018 May; 17(1):56. PubMed ID: 29728104
[TBL] [Abstract][Full Text] [Related]
36. Impact of opportunistic testing in a systematic cervical cancer screening program: a nationwide registry study.
Tranberg M; Larsen MB; Mikkelsen EM; Svanholm H; Andersen B
BMC Public Health; 2015 Jul; 15():681. PubMed ID: 26194007
[TBL] [Abstract][Full Text] [Related]
37. Mammography screening in the county of Fyn. November 1993-December 1999.
Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
[TBL] [Abstract][Full Text] [Related]
38. Expanding the upper age limit for cervical cancer screening: a protocol for a nationwide non-randomised intervention study.
Tranberg M; Petersen LK; Elfström KM; Hammer A; Blaakær J; Bennetsen MH; Jensen JS; Andersen B
BMJ Open; 2020 Nov; 10(11):e039636. PubMed ID: 33154056
[TBL] [Abstract][Full Text] [Related]
39. Stress/depression across the COVID-19 pandemic in Denmark.
Cardona M; Andersen LH; Fallesen P; Bruckner TA
BMC Public Health; 2023 Jan; 23(1):169. PubMed ID: 36698122
[TBL] [Abstract][Full Text] [Related]
40. Screening history and FIGO-stages among Danish women with cervical cancer in 2012-2014: a register-based study.
Bchtawi AK; Saritas S; Schledermann D; Christensen RD; Jochumsen KM
Sci Rep; 2019 Dec; 9(1):20390. PubMed ID: 31892698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
